OPM-2人骨髓瘤細(xì)胞、OPM 返回列表頁(yè)

舉報(bào) 評(píng)價(jià)

參考價(jià)

面議

具體成交價(jià)以合同協(xié)議為準(zhǔn)

產(chǎn)品型號(hào)

品牌

廠商性質(zhì)生產(chǎn)商

所在地

在線詢價(jià) 加入對(duì)比查看聯(lián)系電話

更新時(shí)間：2025-02-11 23:05:14瀏覽次數(shù)：8次

聯(lián)系我時(shí)，請(qǐng)告知來(lái)自化工儀器網(wǎng)

同類優(yōu)質(zhì)產(chǎn)品更多>

產(chǎn)品分類品牌分類

細(xì)胞庫(kù) / 細(xì)胞培養(yǎng): 細(xì)胞株 ATCC細(xì)胞原代細(xì)胞干細(xì)胞普通細(xì)胞

全部產(chǎn)品列表

產(chǎn)品簡(jiǎn)介

OPM-2人骨髓瘤細(xì)胞CatalogueNo

詳情介紹

OPM-2 人骨髓瘤細(xì)胞
Catalogue No.: C787
Product Format: a 15 ml centrifuge tube
Culture Properties：懸浮
Complete Growth Medium: 89%1640+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.

Components

Item	Specifications
a 15 ml centrifuge tube	2X10⁶
Manual	1 copy

191560449-01 （同微-信）

disease after cessation of therapy. Evidence from patients treated with allogenic stem cell transplantation or IFN-α points to an important role of anti-tumor immunity for durable control of CML disease. Data from multiple in vitro and ex vivo studies indicate that BCR-ABL inhibitors may also influence anti-tumor immunity. Varying effects on different immune effector cell suwqts and of the different compounds have been reported, the latter being